Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
43
Number of overlapping holdings
22.4%
% of IBB's 212 holdings also in WDNA
48.9%
% of WDNA's 91 holdings also in IBB
Overlap by Weight
Sector Drift (IBB minus WDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBB |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 2.0% | 2.2% | 2.0% |
|
VERTEX PHARMACEUTICALS INC | 8.0% | 1.6% | 1.6% |
|
UNITED THERAPEUTICS CORP | 1.6% | 1.5% | 1.5% |
|
REGENERON PHARMACEUTICALS | 5.3% | 1.4% | 1.4% |
|
AMGEN INC | 6.9% | 1.4% | 1.4% |
Position Highlights (Non-Overlapping Exposures)
IBB Overweight Relative to WDNA
|
GILEAD SCIENCES INC | 8.9% |
|
VERTEX PHARMACEUTICALS INC | 6.4% |
|
AMGEN INC | 5.5% |
|
REGENERON PHARMACEUTICALS | 3.8% |
|
IQVIA HOLDINGS INC | 3.7% |
 |
ARGENX SE ADR | 3.1% |
 |
METTLER-TOLEDO INTERNATIONAL | 2.7% |
|
WATERS CORP | 2.3% |
|
ALNYLAM PHARMACEUTICALS INC | 1.9% |
 |
BIONTECH SE SPONSORED ADR | 1.7% |
IBB Underweight Relative to WDNA
|
TWIST BIOSCIENCE CORP. | -4.0% |
 |
NOVOZYMES A/S-B SHARES | -2.7% |
|
GERON CORP | -2.3% |
|
FATE THERAPEUTICS INC | -2.2% |
|
AGIOS PHARMACEUTICALS INC | -2.2% |
|
ELI LILLY & CO | -2.1% |
|
BLUEPRINT MEDICINES CORP. | -2.1% |
|
VERICEL CORPORATION | -1.8% |
|
IOVANCE BIOTHERAPEUTICS INC | -1.5% |
|
DANAHER CORP | -1.4% |